Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"CAR-T"|"cell therapy" - Google News
Get the latest updates from "CAR-T"|"cell therapy" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 26 minutes ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial - TipRanks
about 1 hour ago
Imugene’s Azer-cel CAR T Therapy Shows Promising Results in Phase 1b Trial...
EchoBack-CAR T cells: a sonogenetic solution to the persistent challenges of solid tumor immunotherapy - Nature
about 2 hours ago
EchoBack-CAR T cells: a sonogenetic solution to the persistent challenges of solid...
Arsenal Bio lays off 50% of its staff - statnews.com
about 3 hours ago
Arsenal Bio lays off 50% of its staff statnews.com
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025 - us.acrofan.com
about 3 hours ago
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025 us.acrofan.com
In Vivo CAR-T Therapy Shows Safety and Efficacy in Reprogramming 60 Percent of CD8+ T-Cells for Lupus Treatment - geneonline.com
about 3 hours ago
In Vivo CAR-T Therapy Shows Safety and Efficacy in Reprogramming 60 Percent...
MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine. - The Manila Times
about 5 hours ago
MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy...
Potentially Groundbreaking CAR-T Product Shows Early Promise in Lupus - MedPage Today
about 5 hours ago
Potentially Groundbreaking CAR-T Product Shows Early Promise in Lupus MedPage Today
ArsenalBio lays off 50% of staff in pivot from early-stage research - Fierce Biotech
about 5 hours ago
ArsenalBio lays off 50% of staff in pivot from early-stage research Fierce...
Cellares expands Cell Q platform with new tech partners - NJBIZ
about 7 hours ago
Cellares expands Cell Q platform with new tech partners NJBIZ
Cabaletta Bio’s SWOT analysis: CAR-T innovator’s stock faces market skepticism - Investing.com
about 7 hours ago
Cabaletta Bio’s SWOT analysis: CAR-T innovator’s stock faces market skepticism Investing.com
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Bioscie - PharmiWeb.com
about 10 hours ago
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Bioscie PharmiWeb.com